Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection
Status:
Unknown status
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
The primary goal is to study participants with recurrent C. difficile infection (CDI) treated
with lyophilized fecal microbiota transplantation (FMT). The safety, clinical response and
relapse rate in patients will be assessed.